TMG Meaningful Use

From VistApedia
Revision as of 19:00, 25 July 2012 by Kdtop (talk | contribs)
Jump to: navigation, search

7/25/2012

Hello. My name is Kevin Toppenberg, MD. I am a primary care physician in Greeneville, TN. I have been active in the VistA community for at least 7 years, and have used VistA in my office during this time. I have decided to pursue meaningful use certification with VistA. This page will document my progress towards this, and record notes that I make to myself along the way. I hope this is helpful to others.

In CMS terminology, I am an "Eligible Provider" (EP), not a hospital. Also, I am going after Medicare (not Medicaid) certification. So my discussion below will be targeted accordingly.

Q: Where can I find the certification status of WorldVistA?

  • Go to CMS Certified Health IT Products
  • Search for "WorldVistA" -- NOTE: the search engine on this page is flaky. I found that when I clicked the search button, it would return a list of ALL technology. But when I then simply clicked search AGAIN (with WorldVistA still in the search term box), then it would find it.

Q: There seems to be so many steps to be ready to attest meaningful use. It's overwhelming. Any overview sites?

  • When I looked into this a year or so ago, reading the ~80 pages of densely packed legal terms, I gave up. It seemed too daunting. But now that I am revisiting this, it seems to not be too bad at all. I found that I am already doing most of the requirements.
  • I recommend starting with this overview: CMS EHR Meaningful Use Overview. The information I am posting here is from this site.
  • Alternatively, here are the slides from a CMS webinar presentation.
  • Here is another CMS document (2010) document with similar detail.

Q: What's the bottom line? What do I have to do to be ready to attest meaningful use?

  1. Meet 20 of 25 "Meaningful Use Objectives" source
    • Must meet 15 "core" measures
    • Must also meet 5 of 10 possible "menu" set measures
  2. Meet 6 of 41 "Clinical Quality Measures (CQM's)"
    • Must meet 3 required core quality measures
    • must also meet 3 of 38 possible additional quality measures

Q: Can you tell me more about the 15 "core" meaningful use measures? (all are required) They are as follows:

  1. CPOE -- Provider directly enters in orders source
  2. Implement drug-drug and drug-allergy interaction checks source
  3. Maintain and up-to-date problem list of current and active diagnoses source
  4. Generate and transmit permissible prescriptions electronically (eRx) source
  5. Maintain active medication list source
  6. Maintain active medication allergy list source
  7. Record required demographics source
  8. Record required vital signs source
  9. Record smoking status for patients aged 13 yrs and up source
  10. Report clinical quality measures to CMS source
  11. Implement 1 clinical decision support rule source
  12. Provide patients with an electronic copy of their health information source
  13. Provide clinical summaries for patients for each office visit (at least 50% of patients, within 3 days) source
  14. Perform at least 1 test of exchanging key clinical information with another entity electronically source
  15. Protect electronic health information source

Q: What about the 5 "menu" set of meaningful use objectives? (5 of 10 possible are required)

  1. Implement drug formulary checks source
  2. Incorporate lab results into EHR as structured data source
  3. Generate list of patients by specific conditions for quality improvement source
  4. Send patient reminders per patient preference source
  5. Provide patients with timely electronic access to their health information source
  6. Provide patient-specific education resources source
  7. Perform medication reconcilliation source
  8. Send summary care record to other providers source
  9. Submit data to immunization registries source
  10. Submit syndromic surveillance data source

Q: What about the required Clinical Quality Measures (CQM)?

  • As above, providers must report 3 core CQM's
    1. Hypertension: Blood Pressure Measurement -- NQF0013: "Percentage of patient visits for patients aged 18 years and older with a diagnosis of hypertension who has been seen for at least 2 office visits, with blood pressure (BP) recorded."
    2. Preventive Care Screening Measure Pair: details
      • Tobacco Use Assessment
      • Tobacco Cessation Intervention
    3. Adult Weight Screening and Follow-up details
    • OR, 3 alternate core CQM's can be reported. These are to be used of unable to use 3 CQM
    1. NQF 0024 -- BMI for age 2-18
    2. NQF 0041 -- Influenza vaccination
    3. NQF 0038 -- Childhood immunization status
  • An additional 3 from a list of 38 CQM's must be reported. source
    1. Diabetes: Hemoglobin A1c Poor Control details
    2. Diabetes: Low Density Lipoprotein (LDL) Management and Control -- details
    3. Diabetes: Blood Pressure Management details
    4. Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) details
    5. Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)
    6. Pneumonia Vaccination Status for Older Adults details
    7. Breast Cancer Screening details
    8. Colorectal Cancer Screening details
    9. Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD
    10. Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
    11. Anti-depressant medication management: (a) Effective Acute Phase Treatment, (b)Effective Continuation Phase Treatment
    12. Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
    13. Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy details
    14. Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care details
    15. Asthma Pharmacologic Therapy
    16. Asthma Assessment
    17. Appropriate Testing for Children with Pharyngitis
    18. Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer
    19. Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
    20. Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
    21. Smoking and Tobacco Use Cessation, Medical Assistance: a) Advising Smokers and Tobacco Users to Quit, b) Discussing Smoking and Tobacco Use Cessation Medications, c) Discussing Smoking and Tobacco # Use Cessation Strategies
    22. Diabetes: Eye Exam details
    23. Diabetes: Urine Screening details
    24. Diabetes: Foot Exam details
    25. Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol
    26. Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation
    27. Ischemic Vascular Disease (IVD): Blood Pressure Management
    28. Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
    29. Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: a) Initiation, b) Engagement
    30. Prenatal Care: Screening for Human Immunodeficiency Virus (HIV)
    31. Prenatal Care: Anti-D Immune Globulin
    32. Controlling High Blood Pressure
    33. Cervical Cancer Screening
    34. Chlamydia Screening for Women
    35. Use of Appropriate Medications for Asthma
    36. Low Back Pain: Use of Imaging Studies
    37. Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control
    38. Diabetes: Hemoglobin A1c Control (<8.0%) details
Retrieved from "https://vistapedia.com/index.php?title=TMG_Meaningful_Use&oldid=14870"